Medicine for treating infant myocarditis

Abstract

The invention provides a medicine for treating infant myocarditis. The medicine is prepared from the following traditional Chinese medicine raw materials: juncus communis, polygala tenuifolia, fluoritum, amber, bamboo leaf, radix scrophulariae, cassia twig, concha margaritiferallsta, rubia yunnanensis, scutellaria baicalensis, isatis root, oyster, radix polygonati officinalis, dandelion, rhizoma nardostachyos, rhizoma acori graminei, hawthorn, folium isatidis, poria cocos, the root of kudzu vine, rhizoma polygonati, fructus forsythiae, allium macrostemon, pinellia ternate, giant reed shoot, coptis chinensis, phellodendron amurense and lilium brownii. The medicine is mainly prepared from the traditional Chinese medicine components capable of regulating autoimmunity mechanism and decomposing hyperplasia of myocardial fiber organizations, and can be used for regulating the autoimmunity so as to eliminate immune-mediated long-term chronic myocardial inflammatory injury to prevent the further injury of myocardium and decomposing the hyperplasia lesion of myocardial fiber organizations so as to improve myocardial metabolism conditions to gradually restore the functions of myocardial cells, thereby relieving and eliminating chronic myocardial inflammations such as palpitation, shortness of breath, lacking in strength and discomfort of the precordial area. As a result, the infant myocarditis is cured.

Description

Technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a medicine for treating infantile myocarditis. Background technique [0002] Myocarditis refers to localized or diffuse acute, subacute or chronic inflammatory lesions in the myocardium. The relative incidence of viral myocarditis has been increasing in recent years. The severity of the disease is different, and the performance varies greatly. Infants and young children are more severe, and adults are more mild. Mild cases may have no obvious symptoms, and severe cases may be complicated by severe arrhythmia, cardiac insufficiency or even sudden death. [0003] The manifestations of myocarditis in infants and young children are very different. There is no discomfort in the mild cases, and the parents have no way to find out. It is difficult even for the doctor to find out during the examination. Due to the unclear or inaccurate expression of children, young children cannot...

AI Technical Summary

Problems solved by technology

[0004] At present, there has been a lack of effective drugs for the treatment of myocarditis and cardiomyopathy at home and abroad. The effect of western medicine is not ideal, and generally it can only treat the symptoms and not the root cause: myocardial nutrition and metabolic drugs (such as vitamins, coenzyme Q10, inosine) as nutritional supplements; Biological agents, but these drugs themselves may also directly cause myocardial immune damage and cold symptoms, with prominent side effects and high prices, which often delay the disease and even lead to aggravation of the disease